Researchers discover that SLC2A9 is a high-capacity urate transporter in humans
Tuesday, October 7, 2008 - 02:28
in Health & Medicine
An international team of researchers led by Professors Mark Caulfield and Patricia Munroe, from the William Harvey Research Institute at Barts and The London School of Medicine and Dentistry with Chris Cheeseman at the University of Alberta in Canada and Kelle Moley at the University of Washington in USA, have shown that the SLC2A9 gene, which encodes a glucose transporter, is also a high-capacity urate transporter, and thus possibly a new drug target for gout. Their findings are published in this week's PLoS Medicine (7 October 2008).
Read the whole article on Physorg
More from Physorg
Related
- Researchers discover that SLC2A9 is a high-capacity urate transporter in humansTue, 7 Oct 2008, 3:28:50 EDT
- Studies examine treatment for gout and the condition's protective effectsTue, 4 Nov 2008, 13:36:00 EST
- Johns Hopkins scientists out a gene for goutThu, 18 Jun 2009, 18:50:47 EDT
- UCLA researchers clarify function of glucose transport moleculeThu, 3 Jul 2008, 16:28:42 EDT
- Study supports possible role of urate in slowing Parkinson's disease progressionMon, 12 Oct 2009, 17:18:24 EDT